Pulmonary Arterial Hypertension: A Deeper Evaluation of Genetic Risk in the -Omics Era
Pulmonary arterial hypertension (PAH) is a highly heterogeneous disorder with a complex, multifactorial aetiology [...]
Main Authors: | Rajiv D. Machado, Laura Southgate |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/12/11/1798 |
Similar Items
-
Pathophysiology and Treatment of Pulmonary Arterial Hypertension
by: Yoshihiro Fukumoto
Published: (2024-01-01) -
Pulmonary Arterial Hypertension in Genetic and Comorbid Settings: A Step Forward for Precision Medicine
by: Rosalinda Madonna
Published: (2022-11-01) -
Role of Ion Channels in the Development of Pulmonary Arterial Hypertension
by: Fabrice Antigny
Published: (2022-09-01) -
Understanding Neuromuscular Health and Disease: Advances in Genetics, Omics, and Molecular Function
by: William J. Duddy, et al.
Published: (2021-05-01) -
Pulmonary Hypertension: Diagnosis and Management
by: Adam Torbicki
Published: (2021-06-01)